educational part short form

24 Feb 2024

Ophthalmology Hub

10:30 - 11.30 Affordable multi modal imaging options for non-retinal specialists
This session will look closely at various imaging modalities available through a range of more affordable platforms. The lecture will examine the use of OCT, OCT-A, FAF, Retinal camera, UWF, FA and ICGA. We will look at some example cases and understand how non-retinal specialists may find the extra modalities useful for screening pre-surgical patients in cataract and refractive clinics, for example.

12.30 - 13.30 Hanita lenses
In the realm of vision correction, Hanita Lens impants represent a significant step forward, offering individuals a versatile solution to address both distance and near vision concerns simultaneously.
Mr Quah and Mr Walkden will talk about their experience using Hanita lenses and how diffractive and refractive multifocal lenses have revolutionized the field of cataract surgery and refractive lens exchange, providing patients with enhanced visual acuity and reducing dependence on glasses. They will also discuss the science, benefits, and considerations surrounding the use of these lenses.  The session aims to provide valuable insights for eye care professionals, highlighting the strides made in enhancing the quality of surgical vision correction.

14.30 - 15.30 Swiss precision phacoemulsification
Professor Scott will talk about the features and benefits of the Oertli range of Phaco platforms, from anterior segment surgery to a full VR with endo-laser capabilities

Ophthalmology Theatre

10.15 - 11.15 Myopia management: Beyond 20/20
Until recently, eye care practitioners have managed myopia primarily by correcting the optical deficit and providing clear vision with single vision spectacles, contact lenses or refractive surgery. The introduction of interventions which aim to modify eye growth and control the progression of myopia provide the potential for a more ‘therapeutic’ approach to myopia management. This lecture will describe and compare methods of myopia management, including pre-myopia behavioural interventions, and examine the evidence for their efficacy, as well as the areas of uncertainty that remain unresolved.

11.30 - 12.30 The Eye Care Support Pathway
How can Optometry and Ophthalmology work to better embed patient support into NHS systems and change practices and behaviours to improve patient outcomes?

12.45 - 13.45 Slit lamp grand rounds
This session will cover a mixture of clinical cases accompanied by high-resolution immersive slit lamp videos which will support the patient's story to go alongside the cases. Attendees will be able to develop their clinical knowledge and ability to recognise clinical signs demonstrated in the session. The session will be interactive with audience participation technology.
Learning outcome:
Practitioners will recognise the role of the slit lamp in aiding diagnosis for a range of conditions.

14.00 - 15.00 Medico - legal session
In this session Mr Alwitry will share clinical cases which were the subject of medicolegal scrutiny.

15.15 - 16.15 How to access research funding- experiences from the inside track
The panel will aim to encourage members of the audience to consider applying to Fight for Sight and other vision charities. It will show the audience that there is a ‘face’ behind the application process and that there are ways to overcome the barriers that the research community perceives and prevents them from applying. The panel will share experiences and insights while interacting and engaging with any queries from the audience.

16.15 - 17.00 Allied eye healthcare networking
With technology advancing so much, SD-OCT is a more sensitive diagnostic tool than wide field FAF imaging for detecting early-stage HCQ-induced maculopathy. Wide field FAF may not be a necessary addition to SD-OCT in detecting HCQ toxicity.

25 Feb 2024

Ophthalmology Hub

10.30 - 11.30 Clear vision ahead: Strategies for effective myopia management' the significance of myopia management in preserving eye health

12.30 - 13.30 Seeing the future: Innovations in slit lamp technology and slit lamp simulation in ophthalmology

14.30 - 15.30 From measurements to visual clarity: improving refractive outcomes through biometry 

Ophthalmology Theatre

10.15 - 11.15 Guilty till proven otherwise!
Picture quiz on eyelid tumours.

11.30 - 12.30 AI in anterior segment disease - what you need to know!
Everything you need to understand before you start to consider using AI in your practice with a focus on anterior segment disease! 

12.45 - 13.45 Handheld OCT in children
This session will provide an exciting overview of handheld OCT applications in children, relevant to a general audience. This will include clinical applications across numerous conditions, tips for successful image acquisition, and research updates.

14:00 - 15:00 EDI (equity, inclusion and diversity) presentation

15.15 - 16.15 21st century cataract surgery training - a global perspective & cybersight
Orbis’s online training and mentorship service for eye health professionals in developing countries. Further details to follow.

16.15 - 17.00 Research is everyone’s business.
The NHS Constitution pledges to inform patients of research studies in which they may be eligible to participate. The NHS Long Term Plan states that research will play a key part in improving the quality of patient care and health outcomes. The various professional regulatory bodies have mandated that registrants demonstrate an understanding of research, ethics and governance in order to apply research findings and inform best practice. Therefore, all staff working in health and social care are required to have an awareness of research as pertains to their practice. This session will explore how staff can incorporate research into their practice to make it business as usual.

26 Feb 2024

Ophthalmology Hub

10.30 - 11.30 Driving digital transformation in your glaucoma patient pathway I 1 
Are inefficiencies in your clinic causing backlogs? Are your clinics running over schedule?
This 1-hour lecture promises to inspire your approach to data-driven glaucoma management. With unique customer perspectives, case discussions and live workflow demonstrations, join us to see how you can shape the future of your glaucoma patient pathways.
You’ll also gain valuable insights from Royal Bolton Hospital’s Chief Clinical Information Officer & Glaucoma Consultant Ophthalmologist David Haider, as he shares his first-hand experiences of implementing the ZEISS FORUM data management solution, and the significant benefits he’s seen for both patients and clinicians at his hospital.

12.30 - 13.30 Driving digital transformation in your retina patient pathway I 2

14.30 - 15.30 Driving digital transformation in your retina patient pathway I 3

Ophthalmology Theatre

10.15 - 11.15 Widefield OCT angiography
In this session we will explore the research and clinical opportunities that have become possible with the advent of wide-field optical coherence tomography angiography ( OCT-A). The advancement of standard OCT-A imaging to be able to present this much wider field of view has exponentially increased the potential uses for this technology - where previous OCT-A imaging centred on macular disease, wide-field OCT A now includes much more of the retina that is commonly affected by vascular disease. 

11.30 - 12.30 The future of AI and precision medicine in optometry
John Marhsall will outline the necessity for precision digital medicine and highlight the significance of 100% Optical as a platform for unveiling scientific advancements in optometry. He will introduce "Toku Inc" as a trailblazer in the ophthalmic industry, known for its unwavering commitment to scientific advancements and emphasise Toku's approach, rooted in scientific research and development, which has led to pioneering breakthroughs in the field.
There will be a discussion about the scientific significance of Toku's BioAge product, explaining how it leverages cutting-edge science to revolutionise eye care and he will highlight “BioAge“ which represents a precursor to CLAiR, Toku's forthcoming product, which also promises to deliver ground-breaking scientific solutions. The importance of workflow for AI in optometry including harmony integration will also be showcased.
Finally, a look at what’s next for Toku (CKD, HT ) and what’s next for the industry regarding precision digital medicine, and where partnerships can leverage gain for patient outcome.

12.45 - 13.45 Premium IOL technology: A drop, skip and jump away from visual excellence
Join Masara Laginaf, Consultant Ophthalmologist and Purvi Thomson, Lead Optometrist at OCL Vision, for an exploration of premium lens technologies available for your patients. Enhance your expertise in fine-tuning visual outcomes and explore the importance of tear film treatment.

14.00 - 15.00 Masterclass – management of the patient with watery and dry eyes
This enlightening session is presented by Miss Jane Olver, the Founder and Medical Director of Clinica and the co-founder of the British Oculoplastic Surgery Society (BOPSS). You will gain a deeper understanding of how to manage patients with watery and dry eyes.
·       Review the current definitions of dry eyes
·       The anatomy and physiology of watery eyes
·       Understand why a patient with a dry eye can present with a watering eye
·       Introduction of lacrimal paradox and lacrimal vicious circle
·       How to assess a patient with a watery and/or dry eye
·       Updates on treatments for dry eyes and meibomian gland dysfunction.

Registration required. Please contact the organizer for further information.